A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study
Cited by 107
Related Papers
Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine
|Annals of Oncology|2010|168
HER2 Protein and Gene Variation between Primary and Metastatic Breast Cancer: Significance and Impact on Patient Care
|Clinical Cancer Research|2011|98
A phase II study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: changing the natural history of HER2-positive disease
|Annals of Oncology|2006|82
Functional and prognostic significance of the genomic amplification of frizzled 6 (<i><scp>FZD6</scp></i>) in breast cancer
|The Journal of Pathology|2016|74